Insurance won't cover Vyvanse? How to appeal
The short answer
Most plans now prefer generic lisdexamfetamine, the same medicine as Vyvanse, and deny the brand. If a generic works for you, ask your doctor to prescribe it. If you need the brand or another stimulant the plan restricts, ask for an exception with records of what you tried. Vyvanse is also approved for binge eating disorder, and plans treat that use separately.
- StartThe denial letterFind what was denied, the reason, and the deadline to appeal.
- Step 1Appeal to your planMost plans give you 60 to 180 days to ask. The plan reviews its own decision.
- Step 2Go outside the planIf it says no again, someone outside the plan can decide: an independent reviewer, a hearing, or a federal office.
Can’t wait? If waiting could seriously harm your health, ask for a fast appeal. Most plans must decide within 72 hours.
What Vyvanse is approved for
Vyvanse (lisdexamfetamine) is a stimulant. As of November 2026 its FDA label lists two uses:
- ADHD in adults and children 6 and older.
- Moderate to severe binge eating disorder in adults.
The label says Vyvanse is not indicated or recommended for weight loss. It is a Schedule II controlled substance.
Why plans deny Vyvanse
The plan wants a generic first. One insurer's national step therapy policy encourages a Step 1 product before a Step 2 product. Its Step 1 list includes generic lisdexamfetamine and other generic long-acting stimulants. Brand Vyvanse is Step 2. The policy approves a Step 2 product if the patient has tried one Step 1 product.
Prior authorization. Some plans require approval for all ADHD stimulants. One insurer's individual and family plan policy says prior authorization is required for them, and applies preferred-product rules for ADHD.
Binge eating disorder. That policy approves Vyvanse or its generic for binge eating disorder in adults. If your plan excludes weight-loss drugs, point out that binge eating disorder is a separate approved use.
Reading the denial
Job-based plans must name the specific plan provision behind a denial, and you can ask for a free copy of the criteria. "Criteria not met" means the plan wanted more medical proof; see prior authorization denials. "Step therapy" or "try a preferred product first" means the plan wants another drug tried; see step therapy denials. "Non-formulary" means Vyvanse is not on the drug list, which calls for a formulary exception. Check your plan's drug list to see what it prefers.
What your doctor's letter should document
Ask for a letter of medical necessity that answers each criterion, in order, with dated records:
- The diagnosis and its diagnosis code: ADHD or binge eating disorder.
- Each stimulant or non-stimulant tried, with dose, dates and why it stopped.
- Side effects or problems with the generic, if you are asking for the brand.
- For children, school or daily-function notes if the plan asks for them.
Ask the plan for the written criteria it used. Job-based plans must name the specific plan provision behind a denial and give you a free copy of any criteria they relied on. File the internal appeal within 180 days of the denial.
If Vyvanse is not on the drug list, ask for a formulary exception instead of, or alongside, the appeal. Your doctor generally confirms that covered drugs have not worked, will not work as well, or are likely to cause harm. Individual and small-group plans must decide a standard request within 72 hours and an expedited one within 24 hours, and a denial can go to an independent reviewer. See formulary exception letters.
If the plan upholds a denial that turned on medical judgment, you can ask for external review within 4 months of the final decision. Your insurer has to accept the reviewer’s decision.
Medicare, Medicaid and manufacturer help
With a Medicare drug plan, ask for a coverage determination or exception. Your prescriber must provide a statement explaining the medical reason. The plan must decide within 72 hours, or 24 hours if expedited, and Part D exceptions can also cover step therapy and dose limits. You have 65 days to appeal a denial. See Part D appeals.
State Medicaid programs may require prior authorization for any covered drug. See Medicaid appeals.
Questions people ask
Why won't my insurance cover Vyvanse?
Most often because the plan prefers a generic. One insurer lists generic lisdexamfetamine as a Step 1 product and brand Vyvanse as Step 2. Ask your pharmacy or doctor whether the generic is covered.
Is generic Vyvanse the same?
It has the same active ingredient, lisdexamfetamine. If you had a problem with a generic, your doctor can document it for an exception. One plan approves a Step 2 product after one Step 1 trial.
Insurance stopped covering Vyvanse after I'd been on it. What can I do?
First find out why: a lapsed prior authorization, a renewal that asked for proof the drug is working, or a drug-list change. Ask your doctor to resubmit with current records. In individual and small-group plans, being in the middle of a course of treatment on a non-formulary drug qualifies for a 24-hour expedited exception. Medicare drug plans must offer a temporary supply in the first 90 days under a new plan, and that process also covers current enrollees affected by formulary changes.
What if my Vyvanse appeal is denied?
If the denial turned on medical judgment, you can ask for external review by an independent reviewer within 4 months of the plan's final decision. A denied formulary exception in an individual or small-group plan can also go to independent review. With Medicare Part D, if the plan upholds its denial you have 60 days to ask a Part D Independent Review Entity to reconsider; see Part D appeals.
Sources
- National Library of Medicine (DailyMed): VYVANSE (lisdexamfetamine dimesylate) prescribing information (DailyMed)
Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older
- Cigna Healthcare: Attention Deficit Hyperactivity Disorder – Stimulant Medications Step Therapy Policy (Cigna National Formulary, review date 04/29/2026)
This program has been developed to encourage the use of a Step 1 Product prior to the use of a Step 2 Product.
- Cigna Healthcare: Drug Coverage Policy IP0584: ADHD Stimulant Medications for Individual and Family Plans (effective 10/15/2026)
Prior Authorization is required for benefit coverage of ADHD stimulant medications.
- eCFR (Office of the Federal Register): 29 CFR 2560.503-1 -- Claims procedure
Reference to the specific plan provisions on which the determination is based
- HealthCare.gov: Getting prescription medications
Visit your insurer’s website to review a list of prescriptions your plan covers
- HealthCare.gov: Internal appeals
You must file your internal appeal within 180 days (6 months) of receiving notice that your claim was denied.
- eCFR (Office of the Federal Register): 45 CFR 156.122 -- Prescription drug benefits
A health plan must make its determination on a standard exception and notify the enrollee or the enrollee's designee and the prescribing physician (or other prescriber, as appropriate) of its coverage determination no later than 72 hours following receipt of the request.
- HealthCare.gov: External Review
You must file a written request for an external review within 4 months after the date you receive a notice or final determination from your insurer that your claim has been denied.
- Medicare.gov: Appeals in a Medicare drug plan
If you're asking for an exception, your prescriber must provide a statement explaining the medical reason why the exception should be approved.
- eCFR (Office of the Federal Register): 42 CFR 423.568 -- Standard timeframe and notice requirements for coverage determinations
but no later than 72 hours after receipt of the physician's or other prescriber's supporting statement
- eCFR (Office of the Federal Register): 42 CFR 423.572 -- Timeframes and notice requirements for expedited coverage determinations
but no later than 24 hours after receipt of the physician's or other prescriber's supporting statement
- eCFR (Office of the Federal Register): 42 CFR 423.578 -- Exceptions process
An exception to a plan's coverage policy that causes a Part D prescription drug not to be covered because of cost utilization tools, such as a requirement for step therapy, dosage limitations, or therapeutic substitution.
- Legal Information Institute, Cornell Law School: 42 U.S. Code § 1396r-8 - Payment for covered outpatient drugs
A State may subject to prior authorization any covered outpatient drug
- eCFR (Office of the Federal Register): 42 CFR 423.120 -- Access to covered Part D drugs
Ensure access to a temporary supply of drugs within the first 90 days of coverage under a new plan.
This page is general information about appeal rules in the United States. It is not legal or medical advice. Rules can change, and your plan’s documents and your denial letter control the dates that apply to you.